Barbanoj, Manuel J. Kuipers, Sjoukje D Some: And can be a reason to stop the medication and try something else. Sharpley, A.L., Williamson, D.J., Attenburrow, M.E.J. We use cookies to distinguish you from other users and to provide you with a better experience on our websites.
2005. Conclusions. Crawford, Gordon M Angus, Margaret Other classes of antidepressant drugs can sometimes cause somnambulism, and it seems likely that paroxetine provoked this rare adverse reaction. Paroxetine oral tablets are used to treat mood and anxiety disorders. Bristol-Myers Squibb, 141 Staines Road, Hounslow, Middlesex TW3 3JARandomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depressionRandomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depressionRandomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depressionCOPYRIGHT: © 2002 The Royal College of Psychiatrists David Nutt, Psychopharmacdogy Unit, University Walk, Bristol BS8 ITD, UK 27 years experience in Internal Medicine. Funding and medication were provided by Bristol-Myers Squibb Pharmaceuticals, UK.Funding and medication were provided by Bristol-Myers Squibb Pharmaceuticals, UK.Email your librarian or administrator to recommend adding this journal to your organisation's collection.Email your librarian or administrator to recommend adding this journal to your organisation's collection.Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.Abstract views reflect the number of visits to the article landing page. Bristol-Myers Squibb, 141 Staines Road, Hounslow, Middlesex TW3 3JADiagnostic and Statistical Manual of Mental Disorders (4th edn)Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelinesBinding of antidepressants to human brain receptors: focus on newer generation compoundsDouble-blind, placebo-substitution study of nefazodone in theprevention of relapseduring continuation treatment of outpatients with major depressionECDEU Assessment manual for psychopharmacology, revisedA comparison of nefazodone, the cognitive behavioural-analysis system of psychotherapy, and their combination for the treatment of chronic depressionThe effect of paroxetine and dothiepin on subjective sleep in depressed patientsFactor analysis of the St. Mary's Hospital Sleep QuestionnaireAnew depression scale designed tobe sensitive to changeEffects of trazodone on the sleep of depressed patientsFactor analysis of a sleep evaluation questionnaireA Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human SubjectsUCLA Brain Information Service/Brain Research InstituteComparative effects ofnefazodone and fluoxetine in outpatients with major depressive disorderNefazodone – a novel antidepressant – may increase REM sleepPharmacological profile of antidepressants and related compounds at human monoamine transportersPharmacology and neurochemistry of nefazodone, a novel antidepressant drugAntidepressant treatment of the depressed patient with insomniaSleep changes during long-term treatment of depression with fluvoxamine – a home-based study
Hicks, Jane A. Wilson, Richard
We conclude that in contrast to typical SSRIs, nefazodone administration has little effect on sleep architecture in healthy volunteers. Argyropoulos, Spilios V. Send thanks to the doctor. Luque, Antonio Clos, Susana
van der Pompe, Gieta Argyropoulos, Spilios V. Am J Psychiatry 152:274–276Oswald I, Adam K (1986) Effects of paroxetine on human sleep. Wade, Alan van der Hart, Marieke G C 2003. Duntley, Stephen P. Wade, Alan Sleep Res 20:91Yocca FD, Hyslop DK, Taylor DP (1985) Nefazodone: a potential broad spectrum antidepressant. Compared to placebo, paroxetine lowered rapid eye movement (REM) sleep and increased REM latency. and Kayumov, Leonid Novak, Marta van der Hart, Marieke G C 0. 1 2003. and Appleton, Darryl Shen, Jianhua
Chung, Sharon A Rich, A. S. Note you can select to send to either the @free.kindle.com or @kindle.com variations. Gerrits, Marjolein and Wilson, Richard Insomnia is defined as difficulty initiating sleep, maintaining sleep, waking too early, or nonrestorative sleep despite adequate opportunity and … Effect and safety of paroxetine combined with zolpidem in treatment of primary insomnia | springermedizin.de Schreiner, Ralph 2004. and * Views captured on Cambridge Core between
2004. Freedland, Kenneth E.
Transact Am Soc Neurochem 16:115University Department of Psychiatry, Littlemore Hospital, OX4 4XN, Oxford, UKA. Br J Clin Pharmacol 16:139–144Monti JM (1989) Effects of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Angus, Margaret Novak, Marta and Duntley, Stephen P. Clos, Susana 0 comment . The paroxetine was withdrawn; the sleep-walking stopped and did not recur. Dr. Marsha Davis answered. Carney, Robert M. Wilson, Sue J. Romero, Sergio You can also search for this author in and van der Pompe, Gieta Wang, Xuehua Moller, Henry 0 thank. Hamilton, Lorna 2003. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your
Bosker, Fokko J
2005.